FDA Takes It On The Chin In Endotec Ruling

Law360, New York (May 2, 2008, 12:00 AM EDT) -- Joint replacement device manufacturer Endotec Inc. has largely prevailed in a case brought by the U.S. Food and Drug Administration, which accused the company of illegally distributing ankle, knee and joint replacement devices without the agency's approval.

Following a trial held in March, U.S District Judge Kendall Sharp of the Middle District of Florida ruled Monday that Endotec's sale of the ankle and joint devices did not violate portions of the Food, Drug and Cosmetic Act dealing with FDA approval, although the knee devices did. He...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.